Cart
sales@molnova.com
Emzadirib
CAS No. 2301085-04-9
Emzadirib( —— )
Catalog No. M33099 CAS No. 2301085-04-9
Emzadirib (RAD51-IN-2) is a potent inhibitor of RAD51, showing potential anticancer activity and useful for studying DNA damage repair.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 414 | In Stock |
|
| 2MG | 223 | In Stock |
|
| 5MG | 376 | In Stock |
|
| 10MG | 629 | In Stock |
|
| 25MG | 1007 | In Stock |
|
| 50MG | 1311 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEmzadirib
-
NoteResearch use only, not for human use.
-
Brief DescriptionEmzadirib (RAD51-IN-2) is a potent inhibitor of RAD51, showing potential anticancer activity and useful for studying DNA damage repair.
-
DescriptionEmzadirib (RAD51-IN-2) is a RAD51 inhibitor extracted from patent WO2019/051465A1.
-
In VitroEmzadirib exhibts an EC50 of ≤1 μM in activation-induced cytidine deaminase (AID) positive cells.
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetDNA/RNA Synthesis
-
RecptorDNA/RNA Synthesis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2301085-04-9
-
Formula Weight580.76
-
Molecular FormulaC27H40N4O6S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (172.19 mM; Ultrasonic )
-
SMILESCC(C)OC(=O)N[C@H]1CC[C@@H](CC1)c1ncc(s1)-c1ccc(NC(=O)OC(C)C)cc1S(=O)(=O)NC(C)(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Alfredo C. Castro, et al. Rad51 inhibitors. WO2019/051465A1.
molnova catalog
related products
-
Mupirocin
Mupirocin(BRL-4910A) is an antibiotic of the monoxycarbolic acid class; effective against Gram-positive bacteria, including MRSA.
-
Shanzhiside methyl e...
Shanzhiside methylester reduces neuropathic pain by activating spinal GLP-1 receptors and subsequently stimulating microglial β-endorphin expression via the p38 MAPK signaling.
-
Hydroxyurea
Hydroxyurea is an antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase.
